Sivik Global Healthcare LLC Sells 5,000 Shares of Encompass Health Co. (NYSE:EHC)

Sivik Global Healthcare LLC lessened its holdings in Encompass Health Co. (NYSE:EHC) by 8.3% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 55,000 shares of the company’s stock after selling 5,000 shares during the quarter. Encompass Health accounts for approximately 1.7% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 25th biggest position. Sivik Global Healthcare LLC owned about 0.05% of Encompass Health worth $4,718,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Legacy Wealth Asset Management LLC boosted its holdings in shares of Encompass Health by 1.5% in the 1st quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock valued at $712,000 after purchasing an additional 130 shares in the last quarter. Smith Group Asset Management LLC boosted its holdings in shares of Encompass Health by 1.2% during the 1st quarter. Smith Group Asset Management LLC now owns 12,070 shares of the company’s stock valued at $997,000 after acquiring an additional 140 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in shares of Encompass Health by 3.8% during the 4th quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock valued at $259,000 after acquiring an additional 142 shares in the last quarter. Horrell Capital Management Inc. boosted its holdings in shares of Encompass Health by 0.5% during the 1st quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock valued at $2,425,000 after acquiring an additional 147 shares in the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Encompass Health by 31.9% during the 1st quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock valued at $51,000 after acquiring an additional 149 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Trading Up 1.6 %

Shares of EHC stock traded up $1.43 during mid-day trading on Friday, hitting $93.05. The company’s stock had a trading volume of 588,675 shares, compared to its average volume of 644,841. The company’s fifty day simple moving average is $87.72 and its 200-day simple moving average is $83.21. Encompass Health Co. has a 52 week low of $57.55 and a 52 week high of $94.38. The company has a debt-to-equity ratio of 1.14, a quick ratio of 1.37 and a current ratio of 1.37. The company has a market cap of $9.37 billion, a PE ratio of 24.76, a P/E/G ratio of 1.45 and a beta of 0.89.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Monday, August 5th. The company reported $1.11 earnings per share for the quarter, topping the consensus estimate of $1.01 by $0.10. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The firm had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.30 billion. During the same period last year, the company posted $0.95 EPS. The business’s quarterly revenue was up 9.6% on a year-over-year basis. As a group, equities research analysts expect that Encompass Health Co. will post 4.09 earnings per share for the current fiscal year.

Encompass Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be given a $0.17 dividend. The ex-dividend date is Tuesday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.15. This represents a $0.68 annualized dividend and a dividend yield of 0.73%. Encompass Health’s dividend payout ratio (DPR) is 18.38%.

Insider Transactions at Encompass Health

In related news, CFO Douglas E. Coltharp sold 12,260 shares of the company’s stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of $86.34, for a total transaction of $1,058,528.40. Following the transaction, the chief financial officer now directly owns 136,227 shares of the company’s stock, valued at approximately $11,761,839.18. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 2.10% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on EHC. Leerink Partners began coverage on Encompass Health in a report on Wednesday, July 10th. They set an “outperform” rating and a $100.00 price objective on the stock. Barclays cut their price objective on Encompass Health from $113.00 to $109.00 and set an “overweight” rating on the stock in a report on Tuesday, August 6th. Truist Financial raised their price objective on Encompass Health from $100.00 to $104.00 and gave the company a “buy” rating in a report on Thursday, August 15th. Stephens reaffirmed an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a report on Tuesday, August 6th. Finally, UBS Group lifted their target price on Encompass Health from $96.00 to $100.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Nine research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $100.38.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.